Hovingh, G. Kees

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?: CETP as a Target to Lower CVD Risk: Suspension of Disbelief?

Hovingh, G. K., Ray, K. K., & Boekholdt, S. M. (2015) · Circulation

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 31

Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the SELECT trial

Plutzky, J., Bogdański, P., Dagdelen, S., Deanfield, J., Emerson, S., Hovingh, G., Kahn, S., Larsen, S., Latkovskis, G., Lehrke, M., et al. (2024) · Atherosclerosis

Adipokines, Inflammation, and Metabolic DiseasesDiabetes Treatment and Management

Cited by 2